Florida reached a multimillion-dollar agreement with one of the largest oncology medical practices in Florida to resolve state antitrust and consumer protection concerns. The proposed consent decree with Florida Cancer Specialists & Research Institute, LLC follows a civil antitrust investigation into whether the health care provider entered into illegal agreements with competitors that allocated geographic or product markets in violation of the Florida Antitrust Act and the Florida Deceptive and Unfair Trade Practices Act. The potential effect of these agreements was the reduction of choice by consumers seeking cancer treatment. Under the terms of the agreement FCS has agreed to pay more than $20 million in disgorgement of profits and other relief over four years to resolve the investigation. FCS also has agreed to comprehensive injunctive relief, including undertaking a robust compliance program to ensure conformity with Florida’s antitrust laws.
FCS will continue to cooperate with the Florida Attorney General’s ongoing investigation into the alleged allocation scheme. The U.S. Department of Justice Antitrust Division resolved a parallel criminal antitrust investigation of FCS for $100 million in criminal fines.